Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Structural Studies of Nonribosomal Peptide Synthesis (R35GM136235). Andrew Gulick (Principal Investigator). NIH/NIGMS. 4/1/2020-3/1/2025.
  • Exploring New Virulence Factors of the Oral Spirochete Treponema denticola. Michael Malkowski (Co-Principal Investigator). National Institutes of Health. 4/1/2019-3/1/2024.
  • Biology with X-ray free electron lasers. Thomas Grant (Co-Investigator). National Science Foundation. $44,563,810. 10/1/2013-9/1/2023.
  • High-resolution molecular recognition of ligands using solution X-ray scattering. Thomas Grant (Principal Investigator). National Institutes of Health. $1,333,637. 8/1/2019-7/1/2023.
  • Mid-scale RI-1 (M1:DP): Compact X-ray Free-Electron Laser Project. Thomas Grant (Contributor). National Science Foundation. $4,765,713. 11/1/2019-10/1/2022.
  • MRI: Acquisition of a femtosecond laser system for time-resolved studies using CXLS. Thomas Grant (Contributor). National Science Foundation. 5/1/2020-7/20/2021.
  • Light-Induced Protein Quake of Visual Rhodopsin Investigated by Femtosecond Time-Resolved X-Ray Scattering. Thomas Grant (Co-Principal Investigator). National Science Foundation. $800,000. 8/1/2018-7/1/2021.
  • Community Crystallization Resource for Biological Macromolecules. Michael Malkowski (Principal Investigator). National Institutes of Health/NIGMS. 9/1/2017-8/1/2020.
  • The structural basis for modular nonribosomal peptide synthesis(R01GM116957). Andrew Gulick (Principal Investigator). NIH/NIGMS. 1/1/2016-12/1/2019.
  • Structure and Dynamics of Cyclooxygenase Catalysis and Inhibition. Michael Malkowski (Principal Investigator). NIH/NIGMS. 8/1/2015-7/1/2019.
  • Development of HTP Assay for Inhibitors of Aerobactin Production(R01AI116998). Andrew Gulick (Principal Investigator), Thomas Russo (Co-Investigator). National Institutes of Health. 2/1/2016-1/1/2019.